1560 related articles for article (PubMed ID: 28459622)
21. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.
Toren K; Schiöler L; Lindberg A; Andersson A; Behndig AF; Bergström G; Blomberg A; Caidahl K; Engvall J; Eriksson M; Hamrefors V; Janson C; Kylhammar D; Lindberg E; Lindén A; Malinovschi A; Persson HL; Sandelin M; Eriksson Ström J; Tanash HA; Vikgren J; Östgren CJ; Wollmer P; Sköld CM
BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32759170
[TBL] [Abstract][Full Text] [Related]
22. A multicenter family practitioners' research on Chronic Obstructive Pulmonary Disease screening using the COPD Assessment Test.
Demirci H; Eniste K; Basaran EO; Ocakoglu G; Yilmaz Z; Tuna S
Prim Health Care Res Dev; 2017 Nov; 18(6):603-607. PubMed ID: 28714435
[TBL] [Abstract][Full Text] [Related]
23. How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population.
Nishimura K; Oga T; Nakayasu K; Ogasawara M; Hasegawa Y; Mitsuma S
BMJ Open; 2019 Jul; 9(7):e025132. PubMed ID: 31345963
[TBL] [Abstract][Full Text] [Related]
24. Ratio of FEV
Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
[TBL] [Abstract][Full Text] [Related]
25. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
[TBL] [Abstract][Full Text] [Related]
26. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
[TBL] [Abstract][Full Text] [Related]
27. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
[TBL] [Abstract][Full Text] [Related]
28. Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.
Martinez CH; Diaz AA; Meldrum C; Curtis JL; Cooper CB; Pirozzi C; Kanner RE; Paine R; Woodruff PG; Bleecker ER; Hansel NN; Barr RG; Marchetti N; Criner GJ; Kazerooni EA; Hoffman EA; Ross BD; Galban CJ; Cigolle CT; Martinez FJ; Han MK;
Am J Respir Crit Care Med; 2017 Feb; 195(4):464-472. PubMed ID: 27564413
[TBL] [Abstract][Full Text] [Related]
29. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
30. How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.
Quezada WA; Whippo BA; Jellen PA; Leidy NK; Mannino DM; Kim KJ; Han MK; Houfek JF; Make B; Malley KG; Meldrum CA; Rennard SI; Yawn BP; Martinez FJ; Thomashow BM;
Chest; 2017 Oct; 152(4):761-770. PubMed ID: 28414029
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
[TBL] [Abstract][Full Text] [Related]
32. Fixed ratio or lower limit of normal for the FEV
Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
[TBL] [Abstract][Full Text] [Related]
34. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
[TBL] [Abstract][Full Text] [Related]
35. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
36. The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?
Gupta N; Pinto L; Benedetti A; Li PZ; Tan WC; Aaron SD; Chapman KR; FitzGerald JM; Hernandez P; Marciniuk DD; Maltais F; O'Donnell DE; Sin D; Walker BL; Bourbeau J;
Chest; 2016 Nov; 150(5):1069-1079. PubMed ID: 27364603
[TBL] [Abstract][Full Text] [Related]
37. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
[TBL] [Abstract][Full Text] [Related]
38. Parameter D: New Measure of Airflow Obstruction.
Bhatt SP; Nakhmani A; Thimmegowda NM; Sthanam V; Wilson CG; Bhakta NR; Kim YI; Bodduluri S
Ann Am Thorac Soc; 2023 Jul; 20(7):993-1002. PubMed ID: 36989246
[No Abstract] [Full Text] [Related]
39. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
[TBL] [Abstract][Full Text] [Related]
40. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
